Arkolith/Insider Trading/VKTX/Form 4

Singleton J Matthew

DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Oct 25, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 25, 2024Sell(S)16K$79.50$1.3M10K
Oct 25, 2024Option exercise(M)16K$4.48$72K26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 25, 2024Option exercise(M)16K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-117513) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML